{"id":127821,"date":"2021-09-18T17:22:18","date_gmt":"2021-09-19T00:22:18","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2021\/09\/excisions-crispr-gene-editing-therapy-for-hiv-is-heading-into-human-testing-after-fda-clearance"},"modified":"2021-09-18T17:22:18","modified_gmt":"2021-09-19T00:22:18","slug":"excisions-crispr-gene-editing-therapy-for-hiv-is-heading-into-human-testing-after-fda-clearance","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2021\/09\/excisions-crispr-gene-editing-therapy-for-hiv-is-heading-into-human-testing-after-fda-clearance","title":{"rendered":"Excision\u2019s CRISPR gene editing therapy for HIV is heading into human testing after FDA clearance"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/excisions-crispr-gene-editing-therapy-for-hiv-is-heading-into-human-testing-after-fda-clearance2.jpg\"><\/a><\/p>\n<p>A CRISPR-Cas9 gene editing technology that has shown promise in clearing HIV from mice is headed into human testing.<\/p>\n<p>Excision BioTherapeutics will usher the CRISPR-based therapy EBT-101 into clinical trials after the FDA cleared an investigational new drug application, according to the company\u2019s <a href=\"https:\/\/www.globenewswire.com\/news-release\/2021\/09\/15\/2297456\/0\/en\/Excision-Receives-FDA-Clearance-of-IND-for-Phase-1-2-Trial-of-EBT-101-CRISPR-Based-Therapeutic-for-Treatment-of-HIV.html\" target=\"_blank\">press release<\/a>.<\/p>\n<p>EBT-101 is under development as a potential virus-clearing treatment for patients with HIV\u2014or, put in the company\u2019s words, \u201ca potential functional cure for chronic HIV.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A CRISPR-Cas9 gene editing technology that has shown promise in clearing HIV from mice is headed into human testing. Excision BioTherapeutics will usher the CRISPR-based therapy EBT-101 into clinical trials after the FDA cleared an investigational new drug application, according to the company\u2019s press release. EBT-101 is under development as a potential virus-clearing treatment for [\u2026]<\/p>\n","protected":false},"author":556,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1902,11],"tags":[],"class_list":["post-127821","post","type-post","status-publish","format-standard","hentry","category-bioengineering","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/127821","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/556"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=127821"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/127821\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=127821"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=127821"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=127821"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}